Staci Wise
Endocrinology, Diabetes & Metabolism · Atlanta, GANPI 1902026800
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,357 and has fallen 97.1% since, to $39 in 2025. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in GA, where the typical reported total is $2,873.
Across 80 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$175
- Lilly USA, LLC$168
- Tandem Diabetes Care, Inc.$127
- AstraZeneca$118
- Corcept Therapeutics$82
- Merck$70
- plus $760 from 20 others
What the payments were for
- Food & beverage$1,499100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 5 | $175 |
| Lilly USA, LLC | 14 | $168 |
| Tandem Diabetes Care, Inc. | 3 | $127 |
| AstraZeneca | 2 | $118 |
| Corcept Therapeutics | 5 | $82 |
| Merck | 5 | $70 |
| Zealand Pharma US, Inc. | 3 | $68 |
| Esperion Therapeutics, Inc. | 4 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $66 |
| Amgen | 4 | $65 |
| Insulet Corporation | 2 | $63 |
| Dexcom, Inc. | 4 | $61 |
| Antares Pharma, Inc. | 4 | $61 |
| AbbVie | 5 | $60 |
| Abbott | 1 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| IBSA Pharma Inc. | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $24 |
| Cequr Corporation | 2 | $20 |
| Medtronic | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| GRT US Holding, Inc. | 1 | $13 |
| Pfizer | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Mannkind Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIQUA 100/33$113
How this compares
$1,499 in reported general payments places this provider in the 35th percentile of 222 endocrinology, diabetes & metabolism providers in Georgia.
See all endocrinology, diabetes & metabolism providers in Georgia →
Other endocrinology, diabetes & metabolism in Atlanta
- Bruce BodeAtlanta$1.5M
- David RobertsonAtlanta$1.4M
- Jonathan OwnbyAtlanta$291K
- Gulliermo UmpierrezAtlanta$63K
- Francisco PasquelAtlanta$40K
- Norman WelchAtlanta$25K
- Rachel DerrAtlanta$18K
- Kate WheelerAtlanta$17K
- John ZoraAtlanta$16K
- Ernest BeasleyAtlanta$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.